IE831267L - Compostions containing salbutamol - Google Patents

Compostions containing salbutamol

Info

Publication number
IE831267L
IE831267L IE831267A IE126783A IE831267L IE 831267 L IE831267 L IE 831267L IE 831267 A IE831267 A IE 831267A IE 126783 A IE126783 A IE 126783A IE 831267 L IE831267 L IE 831267L
Authority
IE
Ireland
Prior art keywords
salbutanol
pref
cellulose
amt
esp
Prior art date
Application number
IE831267A
Other versions
IE55139B1 (en
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IE831267L publication Critical patent/IE831267L/en
Publication of IE55139B1 publication Critical patent/IE55139B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

New medicaments are aq. dispersions of one or more cellulose derivs. contg. salbutanol and/or one or more physiologically acceptable salts of salbutanol. Suitable cellulose derivs. are those which form an optically transparent or opalescent dispersion in water. Particularly pref. are ethylcellulose, methylcellulose, ethylmethylcellulose, hydroxymethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, hydroxyethyl methylcellulose, hydroxypropylmethylcellulose, hydroxyethyl-ethyl cellulose and carboxymethyl cellulose and its salts. The cellulose deriv. is pref. used in a total amt. of at least 0.1% w/v. For oral formulations, the cellulose deriv. is pref. present in an amt. such as to give a viscosity of 5-10000 (esp. 10-100) cPs. Salbutanol or its salt is pref. present in an amt. of 1-4 (esp.2) mg. per 5 ml., expressed as salbutanol free base. The prepn. pref. has a pH of 3.5. Salbutanol is a beta-stimulant with improved stability. [FR2527442A1]
IE1267/83A 1982-05-27 1983-05-27 Compositions containing salbutamol IE55139B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8215502 1982-05-27

Publications (2)

Publication Number Publication Date
IE831267L true IE831267L (en) 1983-11-27
IE55139B1 IE55139B1 (en) 1990-06-06

Family

ID=10530673

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1267/83A IE55139B1 (en) 1982-05-27 1983-05-27 Compositions containing salbutamol

Country Status (25)

Country Link
JP (1) JPH0629181B2 (en)
AT (1) AT390191B (en)
AU (1) AU567675B2 (en)
BE (1) BE896870A (en)
CA (1) CA1203176A (en)
CH (1) CH656308A5 (en)
DE (1) DE3319356C2 (en)
DK (1) DK167558B1 (en)
ES (1) ES8502336A1 (en)
FI (1) FI81257C (en)
FR (1) FR2527442B1 (en)
GR (1) GR82681B (en)
IE (1) IE55139B1 (en)
IL (1) IL68805A0 (en)
IT (1) IT1174759B (en)
LU (1) LU84828A1 (en)
MY (1) MY8700275A (en)
NL (1) NL192663C (en)
NO (1) NO163166C (en)
NZ (1) NZ204385A (en)
PH (1) PH19601A (en)
PT (1) PT76773B (en)
SE (1) SE454946B (en)
ZA (1) ZA833854B (en)
ZW (1) ZW11883A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3624213A (en) * 1963-10-30 1971-11-30 Merck & Co Inc Method of sterilizing aqueous pharmaceutical solutions employing propylene oxide and entrained air
GB1200886A (en) * 1966-09-23 1970-08-05 Allen & Hanburys Ltd Phenylaminoethanol derivatives
GB1453034A (en) * 1972-12-15 1976-10-20 Boehringer Sohn Ingelheim Pharmaceutical composition for treating spasticity
JPS5831210B2 (en) * 1973-04-09 1983-07-05 武田薬品工業株式会社 antennae
DE2714065A1 (en) * 1977-03-30 1978-10-12 Boehringer Mannheim Gmbh INSTILLATION PREPARATION

Also Published As

Publication number Publication date
SE454946B (en) 1988-06-13
NO163166B (en) 1990-01-08
DK167558B1 (en) 1993-11-22
AU1503983A (en) 1983-12-01
BE896870A (en) 1983-11-28
FI831893L (en) 1983-11-28
ES522752A0 (en) 1985-01-01
PT76773A (en) 1983-06-01
PT76773B (en) 1986-03-27
NL192663C (en) 1997-12-02
SE8303012L (en) 1983-11-28
CH656308A5 (en) 1986-06-30
CA1203176A (en) 1986-04-15
FI81257B (en) 1990-06-29
SE8303012D0 (en) 1983-05-27
DK241783A (en) 1983-11-28
IE55139B1 (en) 1990-06-06
FI81257C (en) 1990-10-10
FR2527442A1 (en) 1983-12-02
NL8301900A (en) 1983-12-16
PH19601A (en) 1986-05-27
AT390191B (en) 1990-03-26
IL68805A0 (en) 1983-09-30
NZ204385A (en) 1986-07-11
ZW11883A1 (en) 1984-12-19
JPH0629181B2 (en) 1994-04-20
NL192663B (en) 1997-08-01
FR2527442B1 (en) 1987-07-17
DE3319356C2 (en) 1996-07-04
LU84828A1 (en) 1985-03-21
AU567675B2 (en) 1987-12-03
IT1174759B (en) 1987-07-01
NO831875L (en) 1983-11-28
GR82681B (en) 1985-02-07
DK241783D0 (en) 1983-05-27
JPS591411A (en) 1984-01-06
ES8502336A1 (en) 1985-01-01
IT8348384A0 (en) 1983-05-27
ZA833854B (en) 1985-01-30
MY8700275A (en) 1987-12-31
NO163166C (en) 1990-05-02
ATA195283A (en) 1989-09-15
DE3319356A1 (en) 1983-12-01
FI831893A0 (en) 1983-05-27

Similar Documents

Publication Publication Date Title
ZA912793B (en) Pharmaceutical formulations
HK41994A (en) Sustained release etodolac
AR002976A1 (en) PARENTERAL PHARMACEUTICAL FORMULATIONS OF LONG-TERM EFFECT OF INSULIN; CRYSTALS OF SUCH ANALOGUES APPLICABLE IN SUCH FORMULATIONS AND PROCEDURE OF THE FORMULATIONS MENTIONED
ATE116844T1 (en) ORAL MEDICINAL FORMS CONTAINING VARIOUS CELLULOSE ETHERS WITH CONTROLLED RELEASE OF ACTIVE INGREDIENTS.
HK95590A (en) Controlled release naproxen and naproxen sodium tablets
ES2096781T3 (en) COMPOSITIONS OF CONTROLLED RELEASE OXICODONS.
ES8608864A1 (en) Sheet-like preparation
KR100257803B1 (en) Stable hydrated cephalosporin dry powder for oral suspension formulation
IE970588A1 (en) Controlled release pharmaceutical compositions containing tiagabine
SE8207167D0 (en) METHOD OF PREPARING THERAPEUTIC COMPOUNDS WITH EXTENDED DELIVERY TIME BASED ON HYDROXYPROPYLMETHYL CELLULOSA
KR920003971A (en) Eye drop composition
ES8609325A1 (en) Derivatives of Guanine, process for their preparation and a pharmaceutical preparation.
GB1465347A (en) Composition
CA2062412A1 (en) Lowering blood cholesterol levels using water soluble cellulose ethers
CA2057291A1 (en) A stable pharmaceutical composition of human calcitonin
HUP9801414A2 (en) Liquid aqueous pharmaceutical compositions comprising sodium alginate and potassium bicarbonate
EP0315401A3 (en) Xanthine derivatives and their preparation and pharmaceutical formulation
JP2634436B2 (en) Topical ophthalmic composition containing lambsan gum
ES8502336A1 (en) Medicinal composition
IE880250L (en) Parenteral suspensions
GB1333126A (en) Chloramphenicol palmitate preparations
JP2002226315A (en) Intraoral humectant for denture
US3122578A (en) Complexes of tetracycline antibiotics and preparation of same
ES2004807A6 (en) PROCEDURE FOR THE PRODUCTION OF A NASAL PHARMACEUTICAL COMPOSITION OF OCTREOTIDE
EP0354042A3 (en) Aminobenzoic-acid derivatives to reduce side effects induced by an administration of immuno-suppressant

Legal Events

Date Code Title Description
MK9A Patent expired